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derived from the checklist on health 
research priority setting.1 A three-stage 
consultation process was developed to 
enable the inclusion of a broad range 
of different stakeholders. In stage 
one, four workshops of 1 day each 
were held. Each focused on a diﬀ erent 
research domain: reproductive, 
maternal,  and child health; 
communicable diseases; healthy 
lifestyles; and health systems. These 
four research domains are aligned with 
the key result areas of the Papua New 
Guinea National Health Plan 2011–20.4 
During these workshops, technical 
experts brainstormed on the values 
that should underlie the development 
of the agenda, discussed which health 
areas were relevant to the agenda 
within each research domain, and 
identified 10–15 research topics for 
each research domain. In stage two, 
during a workshop of 2 days, senior 
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National health research agendas 
are important for helping to allocate 
funding to research areas of greatest 
need, and for aiding countries that 
receive donor funding to develop 
ownership and control over their 
national health research portfolios.1 
However, before 2013, Papua New 
Guinea did not have an agenda 
of this kind. Here, we describe the 
development of the Papua New Guinea 
National Health and HIV Research 
Agenda (NHHRA) for 2013–18.
The Papua New Guinea Health 
Research Policy2 calls for research in 
the country to target national health 
priorities. The NHHRA is the answer to 
this call. It includes the ﬁ rst high-level 
research agenda for all areas of health 
in Papua New Guinea. Under this high-
level agenda, it is envisioned that more 
detailed lists of strategic research 
priorities for speciﬁ c health areas can 
subsequently be developed (such as for 
tuberculosis, cancer, HIV, child health, 
or environmental health). The NHHRA 
also includes the ﬁ rst list of strategic 
research priorities for HIV. By starting 
with HIV, this priority-setting exercise 
drew on the lessons learned from 
developing and implementing the 
National Research Agenda for HIV and 
AIDS in Papua New Guinea 2008–13.3 
The strategic research priorities for HIV 
are intended to function as an example 
for the future development of research 
priorities for other health areas. 
Overarching guidance for the 
development of the programme 
and the methods that led to the 
establishment of the NHHRA were 
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Domain Research topic
1 RMCH Research on how community-level postnatal care interventions that are known to be eﬀ ective can be best implemented in the Papua New Guinea context
2 RMCH Research to evaluate current maternal and neonatal care practices in health facilities and in the community (eg, partogram usage or management of low birthweight or 
prematurity)
3 CD Research on the prevalence and socioeconomic determinants of tuberculosis, drug-resistant tuberculosis (multidrug resistant, extensively drug resistant), and 
tuberculosis/HIV co-infection
4 HS Quality assurance research of medicines and medical supplies along the whole supply chain, from procurement to distribution and storage
5 HL Research on the coverage of access to safe water and proper sanitation, especially rurally and in urban settlements
6 HL Research on solutions for increasing coverage of diagnosis, screening and early detection of cancer in Papua New Guinea, with a view to understanding the relative 
burden of diﬀ erent cancers (eg, breast, cervical, liver, and oral cancers)
7 CD Research on the causes of treatment failure, in particular the causes of poor adherence to treatment for tuberculosis, HIV, and HIV/tuberculosis co-infection and how 
adherence can be improved
8 RMCH Research on the barriers and enablers to accessing supervised delivery in health facilities. 
9 CD Research on the magnitude and determinants of drug resistance for tuberculosis, malaria, pneumonia, meningitis, sexually transmitted infections, and HIV
10 RMCH Research on the serotype distribution of major pathogens causing pneumonia and meningitis and their susceptibility to antibiotics
11 RMCH Research on the eﬀ ectiveness and feasibility of diﬀ erent mechanisms for introducing or scaling up coverage of new and existing vaccines (eg, outreach or supplementary 
immunisation activity or introduction of immunisation at health post level)
12 CD Research on the size, geographical distribution and HIV and health-care seeking behaviours of most-at-risk populations for HIV and sexually transmitted infections
13 HL Research on the cost-eﬀ ectiveness and sustainability of diﬀ erent possible systems for safe waste disposal (including urban solid waste, waste water, medical waste, and 
chemical waste)
14 HL Research on the prevalence, determinants, and burden of violence, especially gender-based violence, and on the eﬀ ectiveness of interventions
15 HS Research on why there is low utilisation of health information and how this can be improved at all levels of the health system
16 RMCH Research on sexual and reproductive health knowledge, attitudes, and practices of youth and adolescents (eg, preventing unwanted pregnancy and sexually transmitted 
infections)
17 RMCH Research on the prevalence of vaccine preventable diseases to inform planning and monitoring of immunisation programmes 
18 HS Research on the satisfaction of health workers with their working conditions and on solutions for improving recruitment and retention of health workers
19 HS Research on the factors that impact on the quality of health workforce performance.
20 HL Epidemiological studies on the burden of diﬀ erent mental health problems, in particular at community level
RMCH=reproductive, maternal, and child health research. CD=communicable disease research. HS=health systems research. HL=research on healthy lifestyles. 
Table: The top 20 research priorities for all areas of health in Papua New Guinea
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priorities for the next 5 years. We 
encourage feedback and discussion 
on this agenda and intend it to be the 
starting point for further dialogue on 
what the most important research 
areas are for Papua New Guinea, and 
how the health research system can be 
improved to address those priorities.
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programmes and practices for sexual 
transmission of HIV and other sexually 
transmitted infections (including 
condom distribution and male 
circumcision); research on biomedical 
tech nologies in the prevention of HIV 
and sexually transmitted infections; 
research on enablers for and barriers 
to creating supportive and safe 
environments for HIV and sexually 
transmitted infection prevention; 
research on HIV testing quality 
assurance and the implementation 
of HIV testing algorithms; research 
on the usefulness and impact of 
innovative systems to record and 
share information on HIV and sexually 
transmitted infection clients and key 
aﬀ ected populations; research on the 
risk of HIV and sexually transmitted 
infection transmission among HIV 
serodiscordant couples; research on the 
lives of marginalised and most-at-risk 
populations; and finally, research on 
the lives of people living with HIV, their 
families, and their communities.
The NHHRA is an important new 
step in strengthening the health 
research system of Papua New 
Guinea.6 A crucial next measure 
for Papua New Guinea will be the 
establishment of a national health 
research grants programme, funded 
by both government and development 
partners, and governed by a new 
national health research council. This 
measure is promoted in the newly 
published Papua New Guinea Health 
Research Policy2 and was strongly 
endorsed by workshop participants. 
Australian Aid, a key development 
partner to Papua New Guinea, 
has shown support for a national 
grants programme,6 and workshop 
participants hoped that other partners 
might follow. Such a programme could 
build on the experience gained with 
grants administration in the area of 
HIV research in Papua New Guinea.
A country’s process of health research 
planning, funding, and evaluation 
should be a continuous cycle. The 
NHHRA makes recommendations for 
Papua New Guinea’s health research 
technical and policy stakeholders 
reﬁ ned and prioritised these topics. In 
stage three, during a 1-day workshop, 
specialised technical experts developed 
a more detailed list of strategic 
research priorities for HIV. A more 
detailed description of how the agenda 
was developed will be published on 
the website of the Papua New Guinea 
National Department of Health. The 
report can also be obtained from the 
corresponding author.
Participants identified the most 
important values that should inform 
the NHHRA, proposing that research 
topics focus on vulnerable populations, 
improve the health system of Papua 
New Guinea, and contribute to 
decision-making and policy-making 
(appendix). After research topics were 
identified for all the relevant health 
areas (appendix), participants agreed 
on a final ranked list of 60 research 
priorities for all areas of health in 
Papua New Guinea. The table presents 
the top 20 research priorities from the 
ﬁ nal ranked list (the appendix shows 
the full list, including participants’ 
views on why each research topic 
is important). Retrospectively, all 
60 research topics were compared by 
two authors (RFV and GC) to Frenk’s 
classification of four research types.5 
This comparison noted that very few 
topics related to biomedical research 
or to clinical efficacy research, and 
that there was a strong focus on 
epidemiology (26 research topics) and 
health systems research (41 research 
topics) across all four research domains. 
For the area of HIV, participants 
agreed on a list of 32 more detailed 
strategic research priorities (appendix). 
The top ten HIV strategic research 
priorities were: research on geographic 
distribution, size estimations, high-
risk practices and HIV/sexually 
transmitted infection serology among 
key affected populations; research 
on adult and paediatric HIV, sexually 
transmitted infection, and HIV-related 
opportunistic infection treatment, 
management, monitoring, and 
outcomes; research on prevention 
See Online for appendix
